SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Editas Medicine Q1 EPS $(0.690) Beats $(0.770) Estimate, Sales $5.723M Miss $7.020M Estimate

Editas Medicine (NASDAQ:EDIT) reported quarterly losses of $(0.690) per share which beat the analyst consensus estimate of $(0.770) by 10.39 percent. This is a 15 percent decrease over losses of $(0.600) per share from

Benzinga · 05/07/2020 11:27

Editas Medicine (NASDAQ:EDIT) reported quarterly losses of $(0.690) per share which beat the analyst consensus estimate of $(0.770) by 10.39 percent. This is a 15 percent decrease over losses of $(0.600) per share from the same period last year. The company reported quarterly sales of $5.723 million which missed the analyst consensus estimate of $7.020 million by 18.48 percent. This is a 176.61 percent increase over sales of $2.069 million the same period last year.